SYDNEY, February 26. /TASS/. Two children have been hospitalized in Australia’s Melbourne on Thursday with suspected Ebola virus.
They are undergoing necessary testing and examination, a representative of the Royal Children’s Hospital in Melbourne said. The results will be known on Thursday evening.
No information is yet available on where the children came from. They are both under 10.
No Ebola cases have been registered in Australia so far.
VACCINES AGAINST EBOLA
Four vaccines against Ebola have been developed and submitted for testing, head of Russia’s Ministry of Health Veronika Skvortsova told journalists on February 18.
The development and testing of vaccines was already one week ahead of schedule, Skvortsova noted. "We prepared four vaccines, each of them has a different basis," the minister said. "At the moment, these vaccines have already entered the stage of clinical trials," she added. One of the vaccines is already being tested on primates, while others will enter this stage in a month.
EBOLA VIRUS OUTBREAK
The Ebola virus outbreak started in December 2013 in West Africa. The number of victims has reached 9,000 people, according to the World Health Organization (WHO). More than 22,500 people are infected. There is still no certified treatment or vaccine against Ebola. Apart from Russia, France and Japan are working on developing the vaccine. A global Vaccine Alliance coordinates the situation with Ebola, saying around 300 million children need urgent vaccination, which will require around Ђ6.7 billion.
Russia has already contributed around $60 million to fighting the spread of the deadly virus. Around $4.5 million was given to WHO, $3 million - to World Bank, $2 million - to UN Children’s Fund, $1 million - to Multi Partner Trust Fund, and $6.6 million - to International Civil Defense Organization (ICDO). A mobile laboratory of Russian virologists has been operating in Guinea from August 2014. Last November, Russia opened a field hospital in the country, and on January 17 this year - an inpatient center for treatment of infectious disease.